126 related articles for article (PubMed ID: 21780129)
41. Association between Interleukin-18 Polymorphisms and Hepatocellular Carcinoma Occurrence and Clinical Progression.
Lau HK; Hsieh MJ; Yang SF; Wang HL; Kuo WH; Lee HL; Yeh CB
Int J Med Sci; 2016; 13(7):556-61. PubMed ID: 27429592
[TBL] [Abstract][Full Text] [Related]
42.
Barooah P; Saikia S; Kalita MJ; Bharadwaj R; Sarmah P; Bhattacharyya M; Goswami B; Medhi S
Viral Immunol; 2020; 33(6):457-467. PubMed ID: 32352886
[TBL] [Abstract][Full Text] [Related]
43. Genetic polymorphism of IL-23R influences susceptibility to HCV-related hepatocellular carcinoma.
Labib HA; Ahmed HS; Shalaby SM; Wahab EA; Hamed EF
Cell Immunol; 2015 Mar; 294(1):21-4. PubMed ID: 25666505
[TBL] [Abstract][Full Text] [Related]
44. TNIP1 Polymorphisms with the Risk of Hepatocellular Carcinoma Based on Chronic Hepatitis B Infection in Chinese Han Population.
Cheng Y; Jiang X; Jin J; Luo X; Chen W; Li Q; Zhang C
Biochem Genet; 2019 Feb; 57(1):117-128. PubMed ID: 30073579
[TBL] [Abstract][Full Text] [Related]
45. Association study of single nucleotide polymorphisms in XRCC1 gene with risk of hepatocellular carcinoma in Chinese Han population.
Bi J; Zhong C; Li K; Chu H; Wang B
Biomed Res Int; 2013; 2013():138785. PubMed ID: 23984316
[TBL] [Abstract][Full Text] [Related]
46. The Contribution of Matrix Metalloproteinase-1 Genotypes to Hepatocellular Carcinoma Susceptibility in Taiwan.
Lai YL; Gong CL; Fu CK; Yueh TC; Tsai CW; Chang WS; Hsiao CL; Yen ST; Li HT; Jeng LB; Wang SC; Bau DT
Cancer Genomics Proteomics; 2017; 14(2):119-125. PubMed ID: 28387651
[TBL] [Abstract][Full Text] [Related]
47. Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population.
Kim WH; Min KT; Jeon YJ; Kwon CI; Ko KH; Park PW; Hong SP; Rim KS; Kwon SW; Hwang SG; Kim NK
Gene; 2012 Aug; 504(1):92-7. PubMed ID: 22583825
[TBL] [Abstract][Full Text] [Related]
48. Genetic variants in IL-33/ST2 pathway with the susceptibility to hepatocellular carcinoma in a Chinese population.
Wei ZH; Li YY; Huang SQ; Tan ZQ
Cytokine; 2019 Jun; 118():124-129. PubMed ID: 29656959
[TBL] [Abstract][Full Text] [Related]
49. IL-23R polymorphisms, HBV infection, and risk of hepatocellular carcinoma in a high-risk Chinese population.
Xu Y; Liu Y; Pan S; Liu L; Liu J; Zhai X; Shen H; Hu Z
J Gastroenterol; 2013 Jan; 48(1):125-31. PubMed ID: 22735941
[TBL] [Abstract][Full Text] [Related]
50. Genetic polymorphisms of XRCC1 gene and susceptibility to hepatocellular carcinoma in Chinese population.
Jiang T; Cui L; Chen L; Liu Z; Ren H
Med Oncol; 2014 Apr; 31(4):887. PubMed ID: 24570146
[TBL] [Abstract][Full Text] [Related]
51. Association between the rs9131 and rs3806792 polymorphisms of the CXCL2 gene and the risk of HBV-related hepatocellular carcinoma in a Guangxi population.
Lu Y; Zeng J; Yang S; Hu Z; Li L; Yu H; Qin X
J Clin Lab Anal; 2020 Aug; 34(8):e23310. PubMed ID: 32267022
[TBL] [Abstract][Full Text] [Related]
52. Association between hepatocellular carcinoma and tumor necrosis factor alpha polymorphisms in South Korea.
Shin SP; Kim NK; Kim JH; Lee JH; Kim JO; Cho SH; Park H; Kim MN; Rim KS; Hwang SG
World J Gastroenterol; 2015 Dec; 21(46):13064-72. PubMed ID: 26672513
[TBL] [Abstract][Full Text] [Related]
53. Interleukin-10 gene polymorphisms and hepatocellular carcinoma susceptibility: a meta-analysis.
Wei YG; Liu F; Li B; Chen X; Ma Y; Yan LN; Wen TF; Xu MQ; Wang WT; Yang JY
World J Gastroenterol; 2011 Sep; 17(34):3941-7. PubMed ID: 22025883
[TBL] [Abstract][Full Text] [Related]
54. Association Between P2RX7 Gene and Hepatocellular Carcinoma Susceptibility: A Case-Control Study in a Chinese Han Population.
Duan S; Yu J; Han Z; Cheng Z; Liang P
Med Sci Monit; 2016 Jun; 22():1916-23. PubMed ID: 27272229
[TBL] [Abstract][Full Text] [Related]
55. Promoter polymorphisms of pri-miR-34b/c are associated with hepatocellular carcinoma.
Son MS; Jang MJ; Jeon YJ; Kim WH; Kwon CI; Ko KH; Park PW; Hong SP; Rim KS; Kwon SW; Hwang SG; Kim NK
Gene; 2013 Jul; 524(2):156-60. PubMed ID: 23632240
[TBL] [Abstract][Full Text] [Related]
56. Matrix Metalloproteinase-11 Gene Polymorphisms as a Risk for Hepatocellular Carcinoma Development in Egyptian Patients.
Saad H; Zahran MA; Hendy O; Abdel-Samiee M; Bedair HM; Abdelsameea E
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3725-3734. PubMed ID: 33369474
[TBL] [Abstract][Full Text] [Related]
57. Role of leptin receptor (LEPR) gene polymorphisms and haplotypes in susceptibility to hepatocellular carcinoma in subjects with chronic hepatitis B virus infection.
Li Z; Yuan W; Ning S; Li J; Zhai W; Zhang S
Mol Diagn Ther; 2012 Dec; 16(6):383-8. PubMed ID: 23090836
[TBL] [Abstract][Full Text] [Related]
58. Alleles and genotypes of polymorphisms of IL-18, TNF-α and IFN-γ are associated with a higher risk and severity of hepatocellular carcinoma (HCC) in Brazil.
Teixeira AC; Mendes CT; Marano LA; Deghaide NH; Secaf M; Elias J; Muglia V; Donadi EA; Martinelli AL
Hum Immunol; 2013 Aug; 74(8):1024-9. PubMed ID: 23632060
[TBL] [Abstract][Full Text] [Related]
59. Association between polymorphism of the interleukin-13 gene and susceptibility to hepatocellular carcinoma in the Chinese population.
Deng Y; Xie M; Xie L; Wang J; Li T; He Y; Li R; Li S; Qin X
PLoS One; 2015; 10(2):e0116682. PubMed ID: 25658755
[TBL] [Abstract][Full Text] [Related]
60. Genetic variants in IL12 influence both hepatitis B virus clearance and HBV-related hepatocellular carcinoma development in a Chinese male population.
Tan A; Gao Y; Yao Z; Su S; Jiang Y; Xie Y; Xian X; Mo Z
Tumour Biol; 2016 May; 37(5):6343-8. PubMed ID: 26631030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
